117 related articles for article (PubMed ID: 2150776)
1. Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action.
Bagdy G; Calogero AE; Szemeredi K; Gomez MT; Murphy DL; Chrousos GP; Gold PW
Brain Res; 1990 Dec; 537(1-2):227-32. PubMed ID: 2150776
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
3. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells.
Calogero AE; Bagdy G; Moncada ML; D'Agata R
J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
5. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.
Bagdy G; Calogero AE; Murphy DL; Szemeredi K
Endocrinology; 1989 Nov; 125(5):2664-9. PubMed ID: 2551661
[TBL] [Abstract][Full Text] [Related]
6. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
7. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
Bervoets K; Millan MJ; Colpaert FC
Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
[TBL] [Abstract][Full Text] [Related]
8. Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin.
Kjaer A; Knigge U; Bach FW; Warberg J
Neuroendocrinology; 1992 Sep; 56(3):419-28. PubMed ID: 1331840
[TBL] [Abstract][Full Text] [Related]
9. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
Berendsen HH; Broekkamp CL
Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
[TBL] [Abstract][Full Text] [Related]
10. Complex actions of serotonergic agonists on cold-stimulated TSH secretion in male rats.
Toivonen M; Männistö PT
Eur J Pharmacol; 1990 May; 180(1):91-102. PubMed ID: 2142094
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
Bagdy G; Kalogeras KT
Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.
Freo U; Holloway HW; Greig NH; Soncrant TT
Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation.
Koenig JI; Gudelsky GA; Meltzer HY
Eur J Pharmacol; 1987 May; 137(1):1-8. PubMed ID: 2956114
[TBL] [Abstract][Full Text] [Related]
14. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami.
Calogero AE; Bernardini R; Margioris AN; Bagdy G; Gallucci WT; Munson PJ; Tamarkin L; Tomai TP; Brady L; Gold PW
Peptides; 1989; 10(1):189-200. PubMed ID: 2787501
[TBL] [Abstract][Full Text] [Related]
15. Isoteoline, a putative serotonin antagonist, inhibits meta -chlorophenylpiperazine, but not 1-(2, -dimethoxy-4-iodphenyl)-2-aminopropane and 8-hydroxy-2-(di-n-propylamino)-tetraline-induced increase of serum prolactin levels.
Zhelyazkova-Savova MD; Negrev N
Pharmacol Res; 2000 Jul; 42(1):93-9. PubMed ID: 10860641
[TBL] [Abstract][Full Text] [Related]
16. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat.
Bagdy G; Calogero AE; Aulakh CS; Szemeredi K; Murphy DL
Neuroendocrinology; 1989 Sep; 50(3):241-7. PubMed ID: 2552339
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane increases brain tryptophan levels in the rat.
Chaouloff F; Baudrie V; Layeillon C; Broqua P
Eur J Pharmacol; 1992 Apr; 214(1):101-3. PubMed ID: 1533838
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
[TBL] [Abstract][Full Text] [Related]
19. Role of CRH in the effects of 5-HT-receptor agonists on food intake and metabolic rate.
Bovetto S; Rouillard C; Richard D
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1231-8. PubMed ID: 8945958
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Glennon RA
Life Sci; 1986 Sep; 39(9):825-30. PubMed ID: 2943960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
